Scandinavian Tobacco Group (STG) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
12 Nov, 2026Executive summary
Focus2030 priorities: stabilize machine-rolled cigars and smoking tobacco, grow handmade cigars, and accelerate Next Generation Products, led by XQS.
9M organic sales grew 0.5%; margins and free cash flow improved. FY EBIT margin and adjusted EPS guidance rose, while sales-growth guidance narrowed after the BREAK and Moro divestment.
Financial highlights
Q3 net sales were DKK 2,434m (+3% YoY; +2.1% organic); EBIT before special items was DKK 484m (+19%), and net profit was DKK 294m (+30%).
9M net sales were DKK 6,627m (-1% reported; +0.5% organic); EBITDA before special items was DKK 1,445m (+8%) and EBIT before special items DKK 1,064m (+6%).
9M free cash flow before acquisitions was DKK 862m (+92%); adjusted EPS was DKK 8.6 versus DKK 8.2. Q3 adjusted EPS was DKK 4.2 versus DKK 3.4.
9M gross margin before special items rose 100bp to 45.5%; EBITDA margin rose to 21.8% from 19.9%. Duty refunds contributed DKK 116m of other income.
Outlook and guidance
FY26 constant-currency net sales growth guidance narrowed to -2% to 0% from -2% to +2%; BREAK and Moro reduce full-year sales by ~1%.
FY EBIT margin before special items guidance rose to 14%-15.5% from 13%-14.5%; adjusted EPS guidance increased to DKK 9.5-DKK 11.5 from DKK 9-DKK 11.
FY free cash flow before acquisitions and divestments guidance remains DKK 1.2bn-DKK 1.4bn; outlook includes ~DKK 200m receivables recovery and ~DKK 200m inventory transfer, partly offset by ~DKK 250m special cash costs.
Q3 shipment timing benefits are expected to reverse in Q4; second-half organic EBIT and margin are expected to decline YoY. Year-end leverage is expected near 2x.
EBITDA before special items is expected broadly in line with last year; reported effective tax rate assumption is 23%-24%, and special items are expected at DKK -225m to -275m.
Latest events from Scandinavian Tobacco Group
- 2025 saw lower earnings and a new strategy focused on cigars, nicotine pouches, and sustainability.STG
AGM 2026 presentation - Stable margins and cash flow in H1 2026; divestment enhances flexibility and guidance is maintained.STG
Q2 2026 - Stable margins and cash flow amid 6% sales decline; handmade cigars up 8% organically.STG
Q1 2026 - 2025 results declined, but Focus2030 and strong cash flow support a stable 2026 outlook.STG
Q4 2025 - Focus2030 targets growth in cigars and nicotine pouches, efficiency, and flexible shareholder returns.STG
CMD 2025 - Q3 net sales up 7.1% on Mac Baren deal; EBITDA margin and organic growth declined.STG
Q3 2024 - Q2 2024 saw 6.3% sales growth, margin gains, and a strategic acquisition for future expansion.STG
Q2 2024 - Record net sales and higher dividend proposed, with all board proposals approved.STG
AGM 2025 - Organic sales fell 8.8% in Q1 2025, prompting lower guidance amid US and FX headwinds.STG
Q1 2025